To summarize, a single high dose of i.v. DEXA reduces significantly the levels of P-CaMKII and P-GluA1-Ser831 in the AMY of MTLE-HS patients in a dose-dependent manner. This evidence concerns the gene GRIA1 and histiocytic sarcoma.